Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01487031 · ClinicalTrials.gov registry record · NA

Music Therapy on Nausea and Pain for Autologous Stem Cell

A NA study, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
108
Enrollment target

NCT01487031 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 108 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01487031, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target

Study Summary

Autologous stem cell transplant (ASCT) is an important therapy for patients with multiple myeloma, non-Hodgkin's lymphoma, and Hodgkin's lymphoma. It has been shown to improve progression free survival and overall survival. However, it is a challenging treatment process both physically and psychologically. It is a procedure with many side effects that can be uncomfortable, painful, and at times, difficult to endure. Complementary therapies, such as music therapy, have potential to be an important adjunct in palliation of symptoms in patients undergoing chemotherapy.

Interventions

  • OTHER Music Therapy
  • OTHER No music therapy

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2011-11
Est. Completion 2013-04
Phase NA

Sponsor

Case Comprehensive Cancer Center

407 total trials

What the Registry Record Tells You About NCT01487031

The ClinicalTrials.gov registry entry for NCT01487031 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Music Therapy is the first listed.

NCT01487031 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01487031 about?

NCT01487031 is a clinical study titled "Music Therapy on Nausea and Pain for Autologous Stem Cell". Autologous stem cell transplant (ASCT) is an important therapy for patients with multiple myeloma, non-Hodgkin's lymphoma, and Hodgkin's lymphoma. It has been shown to improve progression free survival and overall survival. However, it is a challenging treatment process both physically and psycholog...

What is the current status of trial NCT01487031?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2011-11. Estimated completion is 2013-04.

What interventions are being tested in trial NCT01487031?

The interventions under investigation include: Music Therapy (OTHER), No music therapy (OTHER).

Who is sponsoring clinical trial NCT01487031?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.